Recipharm and Synthonics Join Forces in Drug Delivery

News   May 08, 2013

 
Recipharm and Synthonics Join Forces in Drug Delivery
 
 
 

RELATED ARTICLES

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

Psilocybin for Treatment-Resistant Depression

News

Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE